cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Moderna Inc
632 own
290 watching
Current Price
$126.24
$-0.23
(-0.18%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
48,476.16M
52-Week High
52-Week High
217.25
52-Week Low
52-Week Low
115.03
Average Volume
Average Volume
3.64M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
14.5666
iconMarket Capitalization48,476.16M
icon52-Week High217.25
icon52-Week Low115.03
iconAverage Volume3.64M
iconDividend Yield--
iconP/E Ratio14.5666
What does the Moderna Inc do?
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. It has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation; and a research collaboration with Harvard University. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Moderna Inc make?
News & Events about Moderna Inc.
Kiplinger Personal Finance
26days ago
An unexpected profit and promising news on a deal with the EU boosted Moderna stock...
Fool.com Headlines
1month ago
Moderna shares have delivered big for early investors.Moderna (NASDAQ: MRNA) has become one of the most talked-about companies on the planet. That's because the biotech went from zero product revenue to billions thanks to its very first product: the coronavirus vaccine. Those who invested early ...
Accesswire
1month ago
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients with high risk of recurrence following complete resectionResults from the Phase 2b KEYNOTE-942 trial selected for AACR press programCompanies...
Ticker Report
1month ago
Concord Wealth Partners bought a new stake in Moderna, Inc. (NASDAQ:MRNA Get Rating) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 204 shares of the companys stock, valued at approximately $37,000. Other hedge funds and other institutional investors...
PR Newswire
1month ago
Thinking about trading options or stock in Exxon Mobil, Walt Disney, Alphabet, Costco, or Moderna? Thinking about trading options or stock in Exxon Mobil, Walt Disney, Alphabet, Costco, or Moderna? PR Newswire NEW YORK, April 12, 2023 NEW YORK, April 12, 2023 /PRNewswire/ -- InvestorsObserverissues...
Frequently Asked Questions
Frequently Asked Questions
What is Moderna Inc share price today?
plus_minus_icon
Can Indians buy Moderna Inc shares?
plus_minus_icon
How can I buy Moderna Inc shares from India?
plus_minus_icon
Can Fractional shares of Moderna Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Moderna Inc stocks?
plus_minus_icon
What is today’s traded volume of Moderna Inc?
plus_minus_icon
What is today’s market capitalisation of Moderna Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Moderna Inc?
plus_minus_icon
What percentage is Moderna Inc down from its 52-Week High?
plus_minus_icon
What percentage is Moderna Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$126.24
$-0.23
(-0.18%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc
$86.97
$1.82 (2.14 %)
Legend Biotech Corp
Legend Biotech Corp
$63.13
$-0.15 (-0.24 %)
BioNTech SE
BioNTech SE
$105.27
$-3.46 (-3.18 %)
Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
$16.10
$-0.12 (-0.74 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc
$86.97
$1.82 (2.14 %)
Legend Biotech Corp
Legend Biotech Corp
$63.13
$-0.15 (-0.24 %)
BioNTech SE
BioNTech SE
$105.27
$-3.46 (-3.18 %)
Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
$16.10
$-0.12 (-0.74 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00